Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001878313-25-000060
Filing Date
2025-12-04
Accepted
2025-12-04 07:31:28
Documents
1
Period of Report
2025-11-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4a.html 4/A  
1 PRIMARY DOCUMENT form4a.xml 4/A 4220
  Complete submission text file 0001878313-25-000060.txt   5635
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Issuer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address
Vitoc Vlad (Reporting) CIK: 0001913257 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-41455 | Film No.: 251548280